WASHINGTON - Relying on confidential industry research, the Environmental Protection Agency issued a final interim decision today to reapprove glyphosate, the active ingredient in Monsanto/Bayer’s Roundup and the world’s most heavily used pesticide.

The EPA’s assessment contradicts a 2015 World Health Organization analysis of published research that determined glyphosate is a probable carcinogen.

“The Trump EPA’s assertion that glyphosate poses no risks to human health disregards independent science findings in favor of confidential industry research and industry profits,” said Lori Ann Burd, the Center for Biological Diversity’s director of environmental health. “This administration’s troubling allegiance to Bayer/Monsanto and the pesticide industry doesn’t change the trove of peer-reviewed research, by leading scientists, that’s found troubling links between glyphosate and cancer.”

While today’s decision is called interim, the EPA’s practice is to issue interim, rather than final, decisions in its registration-review process for pesticides, which means this is akin to a final decision.

Earlier this week the EPA’s Office of Inspector General announced it’s starting an audit to assess whether the EPA’s pesticide regulatory office adheres to pesticide registration risk assessment regulations, policies and procedures.

SCROLL TO CONTINUE WITH CONTENT

Never Miss a Beat.

Get our best delivered to your inbox.

“The EPA’s pesticide office is clearly willing to bend over backwards, including disregarding its own guidelines for evaluating cancer risks, to give the industry what it wants,” said Burd. “This pesticide is heavily used on food crops, landscaping and even playgrounds, and the public deserves unbiased answers to the basic question of whether it’s safe.”

Emails obtained in litigation brought against Monsanto/Bayer by cancer victims and their families have uncovered a disturbingly cozy relationship between the EPA and the company on matters involving the glyphosate risk assessment.

In one example, when the U.S. Department of Health and Human Services announced it would be reviewing glyphosate’s safety, an EPA official assured Monsanto he would work to thwart the review, saying, “If I can kill this, I should get a medal.”

The Health and Human Services review was delayed for three years and only recently released.

Monsanto/Bayer also enjoys broad support from the Trump White House. A domestic policy advisor in the Trump administration stated, “We have Monsanto’s back on pesticides regulation.”

###

Our pandemic coverage is free to all. As is all of our reporting.

No paywalls. No advertising. No corporate sponsors. Since the coronavirus pandemic broke out, traffic to the Common Dreams website has gone through the roof— at times overwhelming and crashing our servers. Common Dreams is a news outlet for everyone and that’s why we have never made our readers pay for the news and never will. But if you can, please support our essential reporting today. Without Your Support We Won't Exist.

Please select a donation method:

At the Center for Biological Diversity, we believe that the welfare of human beings is deeply linked to nature - to the existence in our world of a vast diversity of wild animals and plants. Because diversity has intrinsic value, and because its loss impoverishes society, we work to secure a future for all species, great and small, hovering on the brink of extinction. We do so through science, law, and creative media, with a focus on protecting the lands, waters, and climate that species need to survive.

Further

Prepping for Saturday's protests in D.C., Mayor Muriel Bowser went for the grand gesture - and a symbolic middle finger to the racist cowering in the White House - and had "Black Lives Matter" painted in yuge yellow letters on the city's main drag. Bowser's action, aimed at recognizing the thousands in the streets "craving to be heard and to be seen," was criticized by some activists as "performative distraction," but many celebrated it as a vital tribute: "We are saying it loud. We are here."

Common Dreams brings you the news that matters.

Sign up for Newsletter

Connect With Us

Support our common dreams.

Can We Count on Your Help Today?

Common Dreams is a small nonprofit with a big mission. Every day of the week, we publish the most important breaking news & views for the progressive community. To remain an independent news source, we do not advertise, sell subscriptions or accept corporate contributions. Instead, we rely on readers like you, to provide the "people power" that fuels our work. Please help keep Common Dreams alive by making a contribution. Thank you. - Craig Brown, Co-founder

Support Our Work -- Join the small group of generous readers who donate, keeping Common Dreams free for millions of people each year. Every donation—large or small—helps us bring you the news that matters.

Support Our Work -- Join the small group of generous readers who donate, keeping Common Dreams free for millions of people each year. Every donation—large or small—helps us bring you the news that matters.